Bryan Smith

Insider Reports History

Location
C/O Urovant Sciences, Inc., 5281 California Avenue, Suite 100, Irvine, CA
Signature
/s/ Paul Little, as attorney-in-fact for Bryan Smith
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bryan Smith:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Eledon Pharmaceuticals, Inc. General Counsel, Corporate Sec Stock Option (right to buy) 151K $735K $1.55 Jan 10, 2025 Direct
Eledon Pharmaceuticals, Inc. General Counsel, Corporate Sec Restricted Stock Units 64.5K Jan 10, 2025 Direct

Insider Reports Filed by Bryan Smith

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELDN Eledon Pharmaceuticals, Inc. Jan 10, 2025 2 $0 4 Jan 13, 2025 General Counsel, Corporate Sec
ELDN Eledon Pharmaceuticals, Inc. Nov 21, 2024 1 $0 4 Nov 22, 2024 General Counsel, Corporate Sec
ELDN Eledon Pharmaceuticals, Inc. Jun 13, 2024 1 $0 4 Jun 14, 2024 General Counsel, Corporate Sec
ELDN Eledon Pharmaceuticals, Inc. May 1, 2023 1 $0 4 May 2, 2023 General Counsel, Corporate Sec
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 General Counsel, Corporate Sec
ELDN Eledon Pharmaceuticals, Inc. Feb 1, 2022 1 $0 4 Feb 2, 2022 General Counsel, Corporate Sec